FDA Approves Dosing Recommendations for Ritonavir in Pediatric Patients - 10/26/05

NIH Issues Short Update to HIV/AIDS Treatment Guidelines - 7/18/05

Boehringer Ingelheim Wins FDA Approval to Market Protease Inhibitor Tipranavir (Aptivus) for Treatment of Drug-resistant HIV - 6/24/05

Comparison of GI Tolerability and Patient Preference for Treatment with the 625 mg and 250 mg Nelfinavir Tablet Formulations - 4/22/05

Among HIV Patients with Nausea, Medicinal Use of Marijuana May Aid Adherence to Antiretroviral Therapy - 1/21/05

Symptoms and Sites of Pain Experienced by AIDS Patients - 09/17/04

Prevalence of Clinical Symptoms Associated with HAART in the Women's Interagency HIV Study - 08/25/04

Differences in Rates of Diarrhea in HIV Patients Receiving Lopinavir-Ritonavir or Nelfinavir - 7/09/04

Diarrhea and Reduced Levels of Antiretroviral Drugs: Improvement with Glutamine or Alanyl-glutamine - 7/07/04

A Regimen of Amprenavir/ Ritonavir/ Lopinavir Produced Low Tolerance and Did Not Prevent Decrease in Amprenavir Levels - 3/29/04

Enhanced Saquinavir (Invirase) Exposure in HIV Patients with Diarrhea and/or Wasting Syndrome -3/10/04

Saquinavir (Invirase) Useful in HIV Patients with Gastrointestinal Problems -3/03/04

Enhanced Saquinavir Exposure in HIV Patients with Diarrhea and/or Wasting Syndrome - 02/04/04

Step-Wise Intervention Eases Diarrhea Linked to PI Viracept (nelfinavir) Therapy - 7/18/03

Prevalence of HIV-related Diarrhea Remains High in Post-HAART Era 05/21/03